Divis Laboratories Ltd | DIVI - Net Income

Stock Price
5,830.00
Daily Change
-26.50 -0.45%
Monthly
-7.90%
Yearly
10.86%
Q2 Forecast
5,728.83

Divis Laboratories Ltd reported INR5.83B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Aurobindo Pharma INR 9.1B 618.4M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Lupin INR 11.76B 3.02B Dec/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025